Payers and PBMs: Increase the effectiveness of patient engagement programs that focus on quality ratings
Looking to improve patient outcomes and quality performance?
AllazoHealth uses artificial intelligence to make a positive impact on individual patient adherence and other medication gaps in care. Adherence and Gap-In-Care measures such as SUPD/SPC are heavily weighted, so improving patient adherence can have a dramatic effect on Star ratings, HEDIS scores, QRS ratings, and Medicaid quality measures.
When it comes to quality ratings such as Star or HEDIS, payers and PBMs need to improve performance every year just to keep pace. AllazoHealth’s AI engine gets smarter over time because it continually learns from new data. So your patient engagement program will keep improving and delivering more value.
Make your patient interventions more efficient
AllazoHealth’s AI engine makes your interventions more efficient because it targets individual patients who are both at risk for non-adherence and who are responsive to interventions. So we free up your resources to concentrate on the patient interventions that are most likely to succeed.
Benefits of AI-powered patient engagement
Study with large regional payer demonstrates 5.5x greater adherence uplift using AI
AllazoHealth AI: Increased likelihood of adherence
In this randomized control study, learn how Blue Cross Blue Shield of North Carolina used artificial intelligence to achieve a 5.5x uplift in medication adherence, as well as a 23% reduction on intervention spend.
Bridging gaps in care with artificial intelligence
As US payers and providers struggle with a fragmented healthcare system, patients with chronic conditions continue to experience gaps in their care. An AARP survey…
Senior medication adherence: the growing problem
By the year 2030 the entire Baby Boomer generation will be age 65 or older. This growing number of senior Boomers will challenge the health…
Improving diabetes adherence: pharmacies, Medicare Advantage Plans and AI
In the field of chronic diseases, Type 2 diabetes ranks high when it comes to the challenges of therapy initiation and non-adherence. Diabetes accounts for…